CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹12 Cr | ₹2.83 Cr | ₹-4.48 Cr | ₹2.74 Cr | ₹-1.35 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD BIOTECH ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹12 Cr |
Mar2023 | ₹2.83 Cr |
Mar2022 | ₹-4.48 Cr |
Mar2021 | ₹2.74 Cr |
Mar2020 | ₹-1.35 Cr |
How is Net Cash Inflow / Outflow of CONCORD BIOTECH Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹12 Cr | 311.12 | |
Mar2023 | ₹2.83 Cr | Positive | |
Mar2022 | ₹-4.48 Cr | Negative | |
Mar2021 | ₹2.74 Cr | Positive | |
Mar2020 | ₹-1.35 Cr | - |
Compare Net Cash Inflow / Outflow of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹17,231.8 Cr | -5.3% | -29.7% | 20.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -5.3% |
-29.7% |
20.5% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses